Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Jan;114(1):1-3.
doi: 10.1111/j.1476-5381.1995.tb14895.x.

Receptors for endothelin-1 in asthmatic human peripheral lung

Affiliations

Receptors for endothelin-1 in asthmatic human peripheral lung

P G Knott et al. Br J Pharmacol. 1995 Jan.

Abstract

[125I]-endothelin-1 ([125I]-ET-1) binding was assessed by autoradiography in peripheral airway smooth muscle and alveolar wall tissue in human non-asthmatic and asthmatic peripheral lung. Levels of specific binding to these structures were similar in both non-asthmatic and asthmatic lung. The use of the receptor subtype-selective ligands, BQ-123 (ETA) and sarafotoxin S6c (ETB), demonstrated the existence of both ETA and ETB sites in airway smooth muscle and in alveoli. In airway smooth muscle from both sources, the great majority of sites were of the ETB subtype. Quantitative analyses of asthmatic and non-asthmatic alveolar wall tissue demonstrated that 29-32% of specific [125I]-ET-1 binding was to ETA sites and 68-71% was to ETB sites. Thus, asthma was not associated with any significant alteration in the densities of ETA and ETB receptors in peripheral human lung.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Lancet. 1991 Mar 23;337(8743):697-701 - PubMed
    1. Anat Embryol (Berl). 1992;185(1):87-96 - PubMed
    1. Am J Physiol. 1992 Sep;263(3 Pt 1):L317-24 - PubMed
    1. Trends Pharmacol Sci. 1993 Jan;14(1):29-32 - PubMed
    1. Br J Pharmacol. 1990 Aug;100(4):786-92 - PubMed

Publication types